Open Access

The expression of fibronectin is significantly suppressed in macrophages to exert a protective effect against Staphylococcus aureus infection

BMC MicrobiologyBMC series – open, inclusive and trusted201717:92

DOI: 10.1186/s12866-017-1003-9

Received: 6 May 2016

Accepted: 7 April 2017

Published: 13 April 2017

Abstract

Background

Fibronectin (Fn) plays a major role in the attachment of Staphylococcus aureus to host cells by bridging staphylococcal fibronectin-binding proteins (FnBPs) and cell-surface integrins. A previous study demonstrated that the phagocytosis of S. aureus by macrophages is enhanced in the presence of exogenous Fn. We recently found that FnBPs overexpression also enhances phagocytic activity. The effect of S. aureus infection on the expression of macrophage Fn was investigated.

Result

The level of Fn secreted by monocytes (THP-1), macrophages, human lung adenocarcinoma (A549) cells, and hepatocellular carcinoma (HepG2) cells in response to S. aureus infection was determined by Western blotting and it was significantly suppressed only in macrophages. The activation of signaling pathways associated with Fn regulation in macrophages and HepG2 cells was also investigated by Western blotting. Erk was activated in both macrophages and HepG2 cells, whereas Src-JNK-c-Jun signaling was only activated in macrophages. A significant decrease in macrophage viability was observed in response to S. aureus infection in the presence of exogenous Fn.

Conclusion

The Src-JNK-c-Jun signaling pathway was activated in macrophages in response to S. aureus infection and resulted in the suppression of Fn expression. This suppression may play a protective role in macrophages against S. aureus infection. This study provides the first demonstration that Fn is suppressed in macrophages by S. aureus infection.

Background

Staphylococcus aureus is one of the leading causes of healthcare-associated and community-acquired infections [1]. This pathogen adheres to and invades host tissues mediated by the interaction between its surface adhesins and the host extracellular matrix (ECM). For example, bacterial attachment can be achieved through fibronectin (Fn) bridge between staphylococcal fibronectin-binding proteins (FnBPs) and the host’s cell-surface integrins [2]. We recently demonstrated that the expression of FnBP is upregulated by antibiotic stress, leading to an increase in cytotoxicity through an increase in bacterial attachment [3].

There are two principal types of Fn, the plasmatic and cell-surface-bound forms, which are generated from the same gene (FN1) transcript by alternative splicing [4]. Only the plasmatic form can bind to and be modified by FnBPs of which the process is essential for integrin binding [5]. This glycoprotein is an important component of the ECM and is functionally implicated in the regulation of several cellular processes, including cell adhesion, migration, as well as tissue repair and the recruitment of inflammatory cells [6]. Fn is majorly produced by hepatocytes, and part of its production is mediated by fibroblasts, monocytes, macrophages, and endothelial cells [7]. It has been reported that the expression of Fn is upregulated by NF-κB and downregulated by the c-Jun/c-Jun homodimer [8, 9]. The regulation of Fn expression is also associated with fibronectin-binding integrins through the modulation of Rho-GTP loading [10]. Several host cell signaling pathways such as focal adhesion kinase (FAK) and steroid receptor coactivator (Src), which are the intracellular tyrosine protein kinase, are activated by the formation of a Fn bridge that links FnBPs and integrins [11]. Once FAK is activated, downstream signaling pathways, such as those associated with MAPK-Erk kinases and Src-c-Jun NH2-terminal kinase (JNK)-c-Jun, which are key regulators controlling the expression of genes related to inflammation and cell adhesion, are also activated [1214]. In addition, the expression level of plasma Fn is decreased and can be used as a biomarker for the evaluation of sepsis [15, 16]. It has been shown that the treatment of macrophages with lipopolysaccharide (LPS), the endotoxin of Gram-negative bacteria, leads to a decrease in Fn expression [16, 17]. However, the underlying mechanism remains unclear.

We recently found that the expression of FnBPs in S. aureus was increased after the application of the sub-lethal doses of cell wall active antibiotics [3]. This increased FnBP expression enhanced phagocytosis of S. aureus by macrophages, similarly to the effect obtained in other studies with the addition of exogenous Fn [18]. We proposed that the expression of Fn by macrophages would be increased in response to S. aureus infection to catch more bacterial cells, and this hypothesis was investigated in the present study. Unexpectedly, we found that the expression of Fn was significantly suppressed and the mechanism underlying was studied.

Methods

Bacterial strains

The allelic replacement of the fnbAB genes by a spectinomycin cassette (spc) was performed by introducing the pMAfnb plasmid into S. aureus strain ATCC12598 to generate the fnbAB-knockout strain SJC1221, according to a method described elsewhere [19]. The spc restricted by BamHI and BglII was flanked by the upstream and downstream arms of the PCR product. The upstream arm originating from the 5′ end of fnbA was amplified by the primer pairs fnbA-F (5′-ATGACCATGGCTACTTGTCTTTGATCTCCGCTATTGT-3′) and fnbA-R (5′-AATTAGATCTCTTGTGTACAAGGGTTTCTGATGACTTG-3′) with BglII and NcoI restriction sites. The downstream arm was restricted by the primer pairs fnbB-F (5′-AGGATCCCTTCATAGTGTCATTG-3′) and fnbB-R (5′-GAGTCGACTGGTACAATCGAAG-3′) with BamHI and SalI restriction sites from the 3′ end of the fnbB. The constructed upstream arm-spc-downstream arm DNA fragment was then cloned into pMAD to yield pMAfnb.

Cells

The human lung adenocarcinoma (A549) and hepatocellular carcinoma (HepG2) cell lines were maintained in DMEM, whereas the human acute monocytic leukemia (THP-1) cell line was maintained in RPMI 1640 medium. THP-1 cells (5 × 106/ml) were differentiated using 10 ng/ml phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich, St. Louis, USA) for 2 days, and after the PMA-containing media was removed, the cells were incubated in fresh RPMI 1640 for an additional day [20]. All cell lines were cultured in serum-free media 1 day prior to bacterial infection. All the cell lines originally purchased from Bioresource Collection and Research Center (BCRC, Taiwan) were kindly given by Professor Hsin-Chih Lai in this department.

Infection of cells

The bacterial infection of the cells was performed by inoculating with different S. aureus strains at a multiplicity of infection (MOI) of 25. Under specified conditions, Fn (200 or 400 μg/ml) was added to the medium to determine the macrophage viability after infection. Cells treated with LPS (100 μg/ml) were used as an experimental control. To determine the Fn-associated signaling in response to bacterial infection, the cells were pre-treated with several signaling inhibitors such as SP600125 (10 μM, JNK inhibitor), SB203580 (25 μM, p38 inhibitor), PP2 (25 μM, Src inhibitor), and PD98059 (25 μM, Erk kinase inhibitor) for 15 min prior to bacterial infection. Concentrations of those inhibitors used in this experiment were according to studies described elsewhere [2124]. The infection was stopped at indicated time points, and the infected cells were washed twice with PBS. After the addition of gentamycin (50 μg/ml) and lysostaphin (10 μg/ml), the cells were incubated for an additional hour to kill and remove the extracellular bacteria. All the chemicals and antibiotics were purchased from Sigma-Aldrich.

Western blotting

The level of secreted Fn and the activation of intracellularly Fn-associated signaling pathways were detected by Western blotting analysis using samples from cell culture supernatants and whole-cell lysates, respectively. Cells were pelleted by centrifugation, and supernatants containing the secreted Fn were removed and filtrated. The pelleted cells were lysed in lysis buffer as described elsewhere, and the concentration of protein in supernatant or cell lysate was determined [25]. Equal amounts of protein (3 μg/lane) were applied to SDS-PAGE gels. The membranes were probed with primary antibody (rabbit monoclonal) against fibronectin (Sigma-Aldrich), Src, Src-P, c-Jun, c-Jun-P (Ser73), p44/42 MAPK (Erk1/2), p44/42-P (Thr202/Tyr204) MAPK (Erk1/2), p38, p38-P (Thr180/Tyr182) or GAPDH (Cell Signaling Technology, Danvers, USA). After washing with TBST, the membranes were probed with secondary horse anti-rabbit HRP-conjugated antibody (Cell Signaling) for 1 h and developed using ECL reagents (Thermo Scientific, Waltham, USA). The blots were photographed and quantified by densitometry using ImageJ software. The results were presented as fold-change expression levels relative to that of the untreated cells and all of the samples were tested in three independent experiments.

Reverse-transcription PCR

S. aureus infected or LPS treated macrophages were collected and pelleted 30 and 60 min post-infection and frozen on dry ice immediately. Total RNA was extracted from cell pellets using the TRIzol (Invitrogen, Waltham, USA) method followed by RQ1 RNase-free DNase (Promega, Madison, USA) treatment to eliminate any remaining DNA. mRNA levels of FN1 were determined by RT-PCR with the iScript Reverse Transcription Supermix (Bio-Rad, Hercules, USA). The expression levels of FN1 were normalized against the GAPDH expression level and quantified by densitometry using ImageJ software. The results were presented as fold-change expression levels relative to that of the untreated cells and all of the samples were tested in three independent experiments.

Determination of cell viability

The viability of macrophages after S. aureus infection in the presence of exogenous Fn was determined using the MTT assay with MTT (3- (4,5-cimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; 0.5 mg/ml; Sigma-Aldrich), as described previously [26]. Four hours post-infection, 100 μl of MTT solution was added to each well, and the plates were incubated at 37 °C for 4 h. The purple formazan crystals were dissolved by adding 100 μl of DMSO, and the absorbance at A570 was spectrophotometrically measured with a reference wavelength of A690. The results are expressed as the percent absorbance of each experimental well as a function of the absorbance of the well containing untreated cells. Three wells were measured for each experimental condition, and each experimental condition was tested in three independent experiments. The attached viable cells were observed by crystal violet staining following to 1 h gentamycin and lysostaphin treatment to eliminate the extracellular bacteria. The cells were fixed by 1% formaldehyde followed by staining with PBS containing 0.5% crystal violet solution (Sigma-Aldrich) for 20 min at room temperature. The cells were gently washed with deionized water and air-dried. The attached damage cells were also visualized by propidium iodide (PI) staining with a commercial apoptosis detection kit (BioVision, Milpitas, USA) by microscopy according to the manufacturer’s instructions.

Statistical analysis

A one-way ANOVA with Games-Howell post-hoc test was used to analyze the experimental data and to compare means. Error bars in the bar graphs of the relative densitometric quantification or cell viability represent as the standard deviation from three experimental repetitions. P-values of less than 0.05 were considered statistically significant.

Results

Expression of fn by macrophages was suppressed by S. aureus infection

Fn plays an important role in bridging the staphylococcal FnBPs to the cell-surface α5β1 integrins. The effect of S. aureus infection on the expression of Fn by macrophages was investigated. A decrease in secreted Fn expression was observed in macrophages after both 2 and 24 h (5.3- and 4.0-fold decreased, respectively) of S. aureus 12,598 infection (Fig. 1). Equal protein loading across all gel lanes was visualized via the Coomassie blue staining (Additional file 1: Figure S1). To study the role of staphylococcal FnBP on macrophage Fn expression, macrophages were infected with the FnBP-deficient strain SJC1221. A mild decrease in Fn expression (2.2- and 2.6-fold decreased 2 and 24 h post-infection, respectively and the same hereafter) was observed suggesting that the FnBP-mediated bacteria-host interaction contributes, at least partly, to the reduction in Fn. There was no difference in the bacterial growth between 12,598 and SJC1221, indicating that the mitigation of the reduction of Fn expression observed with the mutant strain is not due to the bacterial load (Additional file 2: Figure S2). The effect of bacterial cell wall components on the reduction of Fn secretion was investigated through the incubation of heat-killed S. aureus with macrophages, and a reduction in Fn secretion (3.0- and 1.9-fold) was also observed. The filtered supernatant from an overnight bacterial culture was then incubated with macrophages to study the effect of bacterial pathogen-associated molecular patterns (PAMPs) such as lipopeptides, bacterial DNA, and exotoxins, particularly hemolysins, on the suppression of Fn secretion. A suppression of Fn secretion was also detected (5.6- and 2.8-fold), suggesting that the Fn secretion suppressed by S. aureus is multifactorial (Fig. 1). To investigate whether the S. aureus-mediated reduction in Fn secretion was unique to macrophages, the level of Fn secreted by different types of cells, including monocytes (macrophage precursors), A549 cells, and HepG2 cells, after S. aureus infection was determined. The level of Fn by these cells was not significantly changed as was observed with macrophages throughout the period of this experiment except for monocytes 24 h post-infection, probably due to the monocyte-to-macrophage differentiation upon bacterial infection (Fig. 1). Morphological characteristics (pseudopodia) of macrophages were also observed under light field (Additional file 3: Figure S3).
Fig. 1

Expression of secreted Fn is significantly suppressed in macrophages after S. aureus infection. The levels of Fn secreted by THP-1-derived microphages (Mφ), monocytes (Mn), hepatocytes (HepG2), or alveolar basal epithelial cells (A549) after (a) 2 h and (b) 24 h of S. aureus infection were determined and the representative Western blot images are shown. The relative densitometric quantification of above results is shown in (c) and (d), respectively. The numbers ‘12598’ and ‘1221’ represent the S. aureus strains ATCC 12598 and SJC1221 (FnBP deficient), respectively. Other abbreviations: 12,598 dead, heat-killed strain 12,598; 12,598 CM, filtered culture medium containing bacterial exotoxins. LPS was used as an experimental control. The fold change of each sample was compared with untreated cells for each cell type. * P < 0.05

Transcriptional level of FN1 in macrophages upon infection was also determined by RT-PCR. Reduction of the expression of FN1 was observed when macrophages were infected by strain 12,598 and the strongest reduction was observed at 30 min post-infection. Such reduction was mitigated at 2 h post-infection when macrophages were incubated with strain SJC1221 or LPS (Fig. 2).
Fig. 2

Expression of FN1 is suppressed in macrophages after S. aureus infection. a The level of FN1 expression in macrophages after S. aureus infection was determined time-coursely by RT-PCR and the representative images are shown. b The relative densitometric quantification of above results is shown. The numbers ‘12598’ and ‘1221’ represent the S. aureus strains ATCC 12598 and SJC1221 (FnBP deficient), respectively. The fold change of each transcript was compared with untreated cells at each time point and was indicated. * P < 0.05; ** P < 0.01

Reduction in fn expression in macrophages was mediated by c-Jun phosphorylation through the activation of Src signaling

As described above, the expression of Fn in cancer cells is downregulated by c-Jun homodimers, the activation of which is regulated through Src-JNK signaling. Fn is upregulated by c-Jun/c-Fos, the AP-1 heterodimer, upon the activation of p38 MAPK [13]. The activation of Src has been shown to be associated with integrins, and a weaker suppression of Fn was found in macrophage infected with the S. aureus FnBP mutant strain. These results suggest that Src signaling may be crucial to the suppression of Fn expression in S. aureus-infected macrophages. In addition, c-Jun has also been shown to be regulated by Erk [27, 28]. Therefore, the activation of Src, Erk, p38, and c-Jun in macrophages and HepG2 cells after S. aureus infection was then investigated and compared. The results shown in Fig. 3 indicate that Src, Erk, and p38 were activated (phosphorylated) in macrophages after infection with S. aureus 12,598. Activation of c-Jun was also detected, indicating the subsequent activation of JNK. A similar result was observed in macrophages treated with LPS. A weaker activation of Src and c-Jun but not Erk was detected when the FnBP-deficient strain SJC1221 was employed (Fig. 3). However, with the exception of Erk and p38, Src and c-Jun were not activated in HepG2 cells, in contrast to the results observed in macrophages subjected to the same treatment (Fig. 3). The finding that both Erk and p38 were activated in both cell lines suggests that the activation of Erk and p38 induced by S. aureus infection may not play a role in the c-Jun-mediated suppression of Fn. We further investigated the effect of PAMPs and exotoxins secreted to the medium on the fibronectin-associated signaling activation between macrophages and HepG2. A similar result, except for weak activation of Erk in untreated HepG2, was observed as that found when cells were infected with filtered supernatant from an overnight bacterial culture (Additional file 4: Figure S4).
Fig. 3

Activation of c-Jun through Src signaling is triggered in macrophages upon S. aureus infection. a The activation of the Src-JNK-c-Jun, MEK-Erk, and p38 signaling pathways was investigated by determining the expression levels of phosphorylated Src, c-Jun, p38, and Erk, respectively, by Western blotting. Samples were collected 1 h post-infection. b The relative densitometric quantification of above results is shown to indicate the fold change of protein levels relative to untreated cells after normalization to GAPDH. * P < 0.05

To further confirm whether Src-JNK-c-Jun signaling plays a major role in suppressing Fn expression after S. aureus infection, four signaling inhibitors were applied prior to infection. The treatment with inhibitors alone had no significant effect on Fn expression among cell controls, but Src and p38 inhibitors showed cytotoxicity to macrophages (Additional file 5: Figure S5 and Additional file 6: Figure S6). The suppression of Fn in macrophages by S. aureus infection was abrogated to the basal level by pre-treatment either with the Src (PP2) or JNK inhibitor (SP600125), whereas Fn suppression was not affected by pre-treatment with the Erk (PD98059) or p38 (SB203580) inhibitors (Fig. 4). This result suggests that the Src-JNK-c-Jun signaling pathway plays a major role in the suppression of Fn.
Fig. 4

Suppression of Fn is abrogated to the basal level by pre-treatment with a Src or JNK inhibitor. Macrophages were pre-treated with JNK (SP600125), Src (PP2), p38 (SB203580), or Erk (PD98059) inhibitors prior to infection with strain 12,598. The level of secreted Fn 2 h post-infection was determined by Western blotting and the relative densitometric quantification is shown on the top. The fold change of each sample was compared with untreated cells. * P < 0.05

Viability of macrophages after S. aureus infection was decreased in the presence of exogenous fn

The physiological role of Fn suppression in macrophages after S. aureus infection was investigated by the addition of exogenous Fn followed by the evaluation of cell viability using the MTT assay and crystal violet staining. The concentration of plasma Fn is 300 to 400 μg/ml [16]. Therefore, the concentrations of Fn used in our experiment were 200 and 400 μg/ml. In comparison with the Fn-untreated macrophages, a significant decrease (approximately 30%) in cell viability was observed after infection with strain 12,598 in the presence of 400 μg/ml Fn. No obvious difference in cell viability was detected when the macrophages were challenged with the FnBP-deficient strain SJC1221 in the presence of either 200 or 400 μg/ml Fn (Fig. 5a). A similar result was observed when the viable macrophages were visualized by crystal violet staining (Fig. 5b). It is also highly likely that the crystal violet will stain both the mammalian and bacterial cells. Therefore, a PI staining was employed to indicate the cell viability (damage). Results shown in Fig. 5c indicate that more and more strain 12,598-infected macrophages were damaged (red color) with the increase in the concentration of exogenous Fn and such damage was mitigated when strain SJC1221 was used. This result suggests that the reduction in Fn expression in macrophages after S. aureus infection may play a protective role against S. aureus infection.
Fig. 5

Macrophage viability was decreased after S. aureus infection in the presence of exogenous Fn. The viability of macrophages after infection (4 h) with strain 12,598 or SJC1221 in the presence of exogenous Fn was determined by (a) the MTT assay, or visualized either by (b) crystal violet staining or (c) PI staining. Damaged cells were observed by detecting fluorescent PI (red) under a fluorescence microscope with the magnification of 100×. Cell viability was defined as 100% when cells were cultured in medium only (untreated). * P < 0.05

Discussion

In this present study, the expression level of secreted Fn was found to be significantly suppressed in macrophages by S. aureus infection. This suppression has also been observed in macrophages treated with either exotoxins or heat-killed S. aureus, indicating that the Fn suppression mediated by S. aureus is multifactorial. A mitigation of Fn suppression was detected in the co-cultured of FnBP-deficient S. aureus strain with macrophages, implying that the FnBP-mediated bacteria-host interaction may contribute to the Fn suppression observed in macrophages. Fn suppression in macrophages was found to be mediated only through the activation of the Src-JNK-c-Jun signaling pathway. The physiological role underlying Fn suppression may reduce the cytotoxicity caused by S. aureus infection. To the best of our understanding, this study provides the first demonstration of Fn suppression in macrophages upon bacterial infection, at least by S. aureus.

Fn plays an important role in bridging the connection between S. aureus FnBP and cell integrins. Integrins are cell-surface glycoprotein composed of α and β subunits that are involved in the formation of the cell ECM and in the mediation of ECM and pathogen interactions [7, 10, 29]. These proteins have been identified to serve as receptors that trigger several signaling pathways in response to bacterial infection [5, 12, 30, 31]. The pathways investigated in this study are summarized in Fig. 6. The expression of c-Jun or c-Fos has been demonstrated to be associated with the suppression of Fn in cancer cells [9, 32]. The activation of the FAK-associated protein complex plays a central role in controlling the downstream signaling pathways, including c-Jun and c-Fos regulation [29]. Upon stimulation, such as bacterial infection, the Erk-Elk1-c-Fos, Src-JNK-c-Jun, and p38 signaling pathways are activated. However, an association with Toll-like receptors (TLRs) and CD14 is required for the activation of Src in addition to the FAK complex [31, 33]. In contrast, TLR-MyD88-NF-κB signaling is involved in the upregulation of Fn when p65/p50 heterodimers are bound to the FN1 promoter [34]. The formation of p50/p50 homodimers plays a minor role in downregulating Fn expression [35].
Fig. 6

Schematic diagram of the regulation of Fn expression in macrophages after S. aureus infection. The expression of Fn is upregulated by the NF-κB p50/p65 heterodimer through the activation of the TLR-MyD88 signaling pathway. Fn suppression is achieved by the expression and activation of the c-Jun homodimer through the activation of the FAK-Src-JNK signaling pathway after S. aureus infection. The association of FAK with TLRs/CD14 is required for the activation of Src

S. aureus infection-mediated Fn suppression was only observed in macrophages among the distinct types of cells employed in this study (Fig. 1). The activation of Erk, p38 and Src-JNK-c-Jun signaling pathways in macrophages and hepatocytes (HepG2) was then investigated. The activation of Erk and p38 was detected in both cells, whereas Src-JNK-c-Jun signaling was only activated in macrophages upon S. aureus infection (Fig. 3). The expression of Fn was not altered in the presence of Erk and p38 inhibitors, suggesting that both signaling are not involved in the suppression of Fn. However, the expression of Fn was recovered to a basal level by pre-treatment with a JNK inhibitor, indicating that the observed Fn suppression is mediated through the Src-JNK signaling (Fig. 4). Though Src inhibitor (PP2) showed cytotoxicity against macrophages but expression level of Fn was still higher than PP2-free counterpart indicating that the abrogation of the Fn suppression by PP2 was not due to the cell death. It has been demonstrated that α-hemolysin triggered the activation of FAK and Src signaling through the mediation of integrins [36]. Therefore, the Fn suppression as also observed when macrophages were incubated with bacterial culture medium (Fig. 1 and Additional file 4: Figure S4). S. aureus infection plays distinct roles in Fn expression in macrophages and others cells, and this difference is likely due to differences in CD14 expression. CD14 is expressed mainly by macrophages and dendritic cells and acts as a co-receptor together with TLRs for the recognition of PAMPs, such as LPS [33, 37, 38]. LPS, which was used as an experimental control in our study, has been shown to downregulate Fn expression in macrophages, but the underlying mechanism remains unclear and no follow-up study has been reported [17]. LPS also triggers Src signaling and the accumulation of c-Jun, leading to the overexpression of cytokines [39, 40]. As described above, the association of TLRs, CD14, and the FAK complex is required for Src activation [31, 33]. Nevertheless, LPS was used as an experimental technique control and the difference of the suppressive mechanism between S. aureus infection and LPS treatment should be further elucidated.

Through the time course study, the strongest suppression of FN1 transcription and secreted Fn expression was observed at 30 min and 2 h-post infection, respectively (Figs. 1 and 2). We may not rule out that the decreased Fn expression was partially due to the effects on cell viability. Only approximately 10% of the macrophages had been killed following to S. aureus infection (4 h post-infection; Fig. 5a) but a five-fold reduction of the Fn secretion was already observed 2 h post-infection (Fig. 1), as well as the downregulation of the FN1 transcription was observed (Fig. 2). Suppressed Fn expression upon S. aureus infection was only observed in macrophages, not in other cell types, indicating that cell viability had less effect on the Fn expression (Fig. 1). In addition, equal amount of the total exoproteins were loaded per sample for Western blotting (Additional file 1: Figure S1) and the relatively low levels of Fn expression was not caused from the decreased sample loading.

The interesting finding in this study is that the suppression of FN expression in macrophages may play a protective role against S. aureus infection (Fig. 5). The suppression of Fn may reduce the attachment of bacteria to macrophages through the FnBP-Fn-integrin connection. Therefore, the addition of exogenous Fn had no significant effect on the macrophage viability upon infection with FnBP deficient strain SJC1221. Previous studies have demonstrated that the production of TNF-α was increased from macrophages infected by group B streptococci in the presence of exogenous Fn [41]. A large release of TNF-α has been shown to be associated with harmful pathophysiological effects and increased mortality from septic shock [42]. In addition, the abnormally diminished concentration of plasma Fn has been used as a biomarker in evaluating sepsis [15]. The reduction in the plasma Fn concentration observed in patients with sepsis may arise from intravascular coagulation and cryofibrinogenemia, which is likely due to increased plasma Fn catabolism secondary to the intravascular formation of fibrin [15]. However, the mechanisms underlying this reduction remain unclear. Therefore, a reduction in the Fn concentration may be beneficial to the host, at least to macrophages, after S. aureus infection. Macrophages are majorly found in tissues through the differentiation of monocytes when they leave the blood. Thus, such protective mechanisms may be relevant to localized infection in the tissues. However, Fn is also present in the tissues and the effect of tissue Fn on the macrophages against S. aureus infection remains to be elucidated further. An animal model which reflects tissue infection for evaluating the local Fn expression level by immunofluorescent assay can be conducted. In addition, fibroblasts are widely dispersed in connective tissues and the effect of S. aureus infection on the expression of Fn by fibroblasts can be studied in the future.

Conclusions

Our study provides the first demonstration that Fn is suppressed in macrophages by S. aureus infection. This S. aureus infection induced suppression of Fn expression from macrophages was mediated by Src-JNK-c-Jun signaling pathway. This suppression may play a protective role in macrophages against S. aureus infection.

Abbreviations

A549: 

Human lung adenocarcinoma cells

ECM: 

Extracellular matrix

FAK: 

Focal adhesion kinase

Fn: 

Fibronectin

FnBPs: 

Fibronectin-binding proteins

HepG2: 

Hepatocellular carcinoma cells

LPS: 

Lipopolysaccharide

MOI: 

Multiplicity of infection

Spc

Spectinomycin cassette

Src: 

steroid receptor coactivator

THP-1: 

human acute monocytic leukemia

TLRs: 

Toll-like receptors

Declarations

Acknowledgments

This study was kindly supported by the Ministry of Science and Technology, Taiwan (grant No. MOST103-2320-B-182-022), and Research Program of Chang Gung Memorial Hospital (grant No. CMRPD1C0851 ~ 2), Taoyuan, Taiwan.

Availability of data and material

Data supporting this findings can be found in the main paper or additional supporting files.

Authors’ contributions

HYC and JCS made substantial contributions to conception and design. HYC acquisition of data, and analysis and interpretation of data. MHL and CCC conceived of the study, and participated in its design and coordination and helped to draft the manuscript. HYC and JCS gave final approval of the version to be submitted and any revised version. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable. (This manuscripts reporting study does not involve human participants, human data or human tissue.)

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University
(2)
Research Center for Pathogenic Bacteria, Chang Gung University
(3)
Department of Laboratory Medicine, Chang Gung Memorial Hospital
(4)
Department of Biotechnology, National Kaohsiung Normal University

References

  1. Foster TJ, Geoghegan JA, Ganesh VK, Hook M. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat rev Microbiol. 2014;12:49–62.View ArticlePubMedGoogle Scholar
  2. Parker D, Prince A. Immunopathogenesis of Staphylococcus aureus pulmonary infection. Semin Immunopathol. 2012;34:281–97.View ArticlePubMedGoogle Scholar
  3. Chen HY, Chen CC, Fang CS, Hsieh YT, Lin MH, Shu JC. Vancomycin activates σB in vancomycin-resistant Staphylococcus aureus resulting in the enhancement of cytotoxicity. PLoS One. 2011;6:e24472.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Kornblihtt AR, Vibe-Pedersen K, Baralle FE. Human fibronectin: cell specific alternative mRNA splicing generates polypeptide chains differing in the number of internal repeats. Nucleic Acids Res. 1984;12:5853–68.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Agerer F, Michel A, Ohlsen K, Hauck CR. Integrin-mediated invasion of Staphylococcus aureus into human cells requires Src family protein-tyrosine kinases. J Biol Chem. 2003;278:42524–31.View ArticlePubMedGoogle Scholar
  6. Tamura K, Chen YE, Lopez-Ilasaca M, Daviet L, Tamura N, Ishigami T, et al. Molecular mechanism of fibronectin gene activation by cyclic stretch in vascular smooth muscle cells. J Biol Chem. 2000;275:34619–27.View ArticlePubMedGoogle Scholar
  7. Pankov R. Fibronectin at a glance. J Cell Sci. 2002;115:3861–3.View ArticlePubMedGoogle Scholar
  8. Lee BH, Park SY, Kang KB, Park RW, Kim IS. NF-κB activates fibronectin gene expression in rat hepatocytes. Biochem Biophys Res Commun. 2002;297:1218–24.View ArticlePubMedGoogle Scholar
  9. Hayashi Y, Shino Y, Saito K, Tanzawa H. Shirasawa H: c-Jun-mediated repression and transactivation of fibronectin. Mol Med Rep. 2008;1:99–103.PubMedGoogle Scholar
  10. Danen EH, Sonneveld P, Brakebusch C, Fassler R, Sonnenberg A. The fibronectin-binding integrins α5β1 and αvβ3 differentially modulate RhoA-GTP loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis. J Cell Biol. 2002;159:1071–86.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Jun HK, Lee SH, Lee HR, Choi BK. Integrin α5β1 activates the NLRP3 inflammasome by direct interaction with a bacterial surface protein. Immunity. 2012;36:755–68.View ArticlePubMedGoogle Scholar
  12. Agerer F, Lux S, Michel A, Rohde M, Ohlsen K, Hauck CR. Cellular invasion by Staphylococcus aureus reveals a functional link between focal adhesion kinase and cortactin in integrin-mediated internalisation. J Cell Sci. 2005;118:2189–200.View ArticlePubMedGoogle Scholar
  13. Fthenou E, Zong F, Zafiropoulos A, Dobra K, Hjerpe A, Tzanakakis GN. Chondroitin sulfate a regulates fibrosarcoma cell adhesion, motility and migration through JNK and tyrosine kinase signaling pathways. In Vivo. 2009;23:69–76.PubMedGoogle Scholar
  14. Huang C, Rajfur Z, Borchers C, Schaller MD, Jacobson K. JNK phosphorylates paxillin and regulates cell migration. Nature. 2003;424:219–23.View ArticlePubMedGoogle Scholar
  15. Ruiz Martin G, Prieto Prieto J, Veiga de Cabo J, Gomez Lus L, Barberan J, Gonzalez Landa JM, et al. Plasma fibronectin as a marker of sepsis. Int J Infect Dis. 2004;8:236–43.View ArticlePubMedGoogle Scholar
  16. Trotter KM, Beezhold DH, Lause DB. Modulation of macrophage fibronectin secretion by LPS. J Leukoc Biol. 1989;45:515–22.PubMedGoogle Scholar
  17. Yamauchi K, Martinet Y, Crystal RG. Modulation of fibronectin gene expression in human mononuclear phagocytes. J Clin Invest. 1987;80:1720–7.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Shinji H, Sakurada J, Seki K, Murai M, Masuda S. Different effects of fibronectin on the phagocytosis of Staphylococcus aureus and coagulase-negative staphylococci by murine peritoneal macrophages. Microbiol Immunol. 1998;42:851–61.View ArticlePubMedGoogle Scholar
  19. Arnaud M, Chastanet A, Debarbouille M. New vector for efficient allelic replacement in naturally nontransformable, low-GC-content, gram-positive bacteria. Appl Environ Microbiol. 2004;70:6887–91.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Park EK, Jung HS, Yang HI, Yoo MC, Kim C, Kim KS. Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflamm Res. 2007;56:45–50.View ArticlePubMedGoogle Scholar
  21. Prasad KD, Trinath J, Biswas A, Sekar K, Balaji KN, Guru Row TN. Anthrapyrazolone analogues intercept inflammatory JNK signals to moderate endotoxin induced septic shock. Sci Rep. 2014;4:7214.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Zhi H, Dai J, Liu J, Zhu J, Newman DK, Gao C, et al. Platelet activation and thrombus formation over IgG immune complexes requires integrin αIIbβ3 and Lyn Kinase. PLoS One. 2015;10:e0135738.View ArticlePubMedPubMed CentralGoogle Scholar
  23. Meehan AC, Mifsud NA, Nguyen TH, Levvey BJ, Snell GI, Kotsimbos TC, et al. Impact of commonly used transplant immunosuppressive drugs on human NK cell function is dependent upon stimulation condition. PLoS One. 2013;8:e60144.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Bussiere FI, Brossier F, Le Vern Y, Niepceron A, Silvestre A, de Sablet T, et al. Reduced parasite motility and micronemal protein secretion by a p38 MAPK inhibitor leads to a severe impairment of cell invasion by the apicomplexan parasite Eimeria tenella. PLoS One. 2015;10:e0116509.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Hsieh YT, Lin MH, Ho HY, Chen LC, Chen CC, Shu JC. Glucose-6-phosphate dehydrogenase (G6PD)-deficient epithelial cells are less tolerant to infection by Staphylococcus aureus. PLoS One. 2013;8:e79566.View ArticlePubMedPubMed CentralGoogle Scholar
  26. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.View ArticlePubMedGoogle Scholar
  27. Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol. 2004;5:816–26.View ArticlePubMedGoogle Scholar
  28. Rincon M, Conze D, Weiss L, Diehl NL, Fortner KA, Yang D, et al. Conference highlight: do T cells care about the mitogen-activated protein kinase signalling pathways? Immunol Cell Biol. 2000;78:166–75.View ArticlePubMedGoogle Scholar
  29. Hoffmann C, Ohlsen K, Hauck CR. Integrin-mediated uptake of fibronectin-binding bacteria. Eur J Cell Biol. 2011;90:891–6.View ArticlePubMedGoogle Scholar
  30. Harokopakis E, Hajishengallis G. Integrin activation by bacterial fimbriae through a pathway involving CD14, toll-like receptor 2, and phosphatidylinositol-3-kinase. Eur J Immunol. 2005;35:1201–10.View ArticlePubMedGoogle Scholar
  31. Oliveira-Ferrer L, Rossler K, Haustein V, Schroder C, Wicklein D, Maltseva D, et al. C-Fos suppresses ovarian cancer progression by changing adhesion. Br J Cancer. 2014;110:753–63.View ArticlePubMedGoogle Scholar
  32. Reed-Geaghan EG, Savage JC, Hise AG, Landreth GE. CD14 and toll-like receptors 2 and 4 are required for fibrillar a β-stimulated microglial activation. J Neurosci. 2009;29:11982–92.View ArticlePubMedPubMed CentralGoogle Scholar
  33. Ding Y, Qiu Y, Zou L, Tan Z, Dai J, Xu W. Three conserved MyD88-recruiting TLR residues exert different effects on the human TLR4 signaling pathway. Immunol Res. 2015;62:213–21.View ArticlePubMedGoogle Scholar
  34. Tohno M, Shimazu T, Aso H, Kawai Y, Saito T, Kitazawa H. Molecular cloning and functional characterization of porcine MyD88 essential for TLR signaling. Cell Mol Immunol. 2007;4:369–76.PubMedGoogle Scholar
  35. Lee BH, Kim MS, Rhew JH, Park RW, de Crombrugghe B, Kim IS. Transcriptional regulation of fibronectin gene by phorbol myristate acetate in hepatoma cells: a negative role for NF-κB. J Cell Biochem. 2000;76:437–51.View ArticlePubMedGoogle Scholar
  36. Wilke GA, Bubeck Wardenburg J. Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus α-hemolysin-mediated cellular injury. Proc Natl Acad Sci U S A. 2010;107:13473–8.View ArticlePubMedPubMed CentralGoogle Scholar
  37. Nakata T, Yasuda M, Fujita M, Kataoka H, Kiura K, Sano H, et al. CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of toll-like receptors 2 and 1 without binding to the complex. Cell Microbiol. 2006;8:1899–909.View ArticlePubMedGoogle Scholar
  38. Liu YW, Chen CC, Wang JM, Chang WC, Huang YC, Chung SY, et al. Role of transcriptional factors Sp1, c-Rel, and c-Jun in LPS-induced C/EBPdelta gene expression of mouse macrophages. Cell Mol Life Sci. 2007;64:3282–94.View ArticlePubMedGoogle Scholar
  39. Napolitani G, Bortoletto N, Racioppi L, Lanzavecchia A, D’Oro U. Activation of src-family tyrosine kinases by LPS regulates cytokine production in dendritic cells by controlling AP-1 formation. Eur J Immunol. 2003;33:2832–41.View ArticlePubMedGoogle Scholar
  40. Peat EB, Augustine NH, Drummond WK, Bohnsack JF, Hill HR. Effects of fibronectin and group B streptococci on tumour necrosis factor-α production by human culture-derived macrophages. Immunology. 1995;84:440–5.PubMedPubMed CentralGoogle Scholar
  41. Vallejo JG, Knuefermann P, Mann DL, Sivasubramanian N. Group B Streptococcus induces TNF-α gene expression and activation of the transcription factors NF-κB and activator protein-1 in human cord blood monocytes. J Immunol. 2000;165:419–25.View ArticlePubMedGoogle Scholar
  42. Hughes CB, Gaber LW, Mohey el-Din AB, Grewal HP, Kotb M, Mann L, et al. Inhibition of TNFα improves survival in an experimental model of acute pancreatitis. Am Surg. 1996;62:8–13.PubMedGoogle Scholar

Copyright

© The Author(s). 2017